Keith Crandell

Sits on 4 boards. Last updated September 27, 2026

Time on boards

Boards served
4
Current seats
4
Board service
11 years
Director since
2023

11 years of board service in total across 4 boards, counting each seat separately. Longest: Quanterix Corporation, 3 years.

3 years ยท Since 2023
3 years ยท Since 2023
908 Devices Inc. Director
3 years ยท Since 2023
Kardigan Inc. Director
3 months ยท Since 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 1, 2026 Boundless Bio Inc. Option exercise +16,000 $1.03 $16,480
Jul 1, 2026 Boundless Bio Inc. Open-market sale โˆ’16,000 $2.49 $39,840
Jun 10, 2026 908 Devices Inc. Option exercise +14,083 โ€” โ€”
Feb 5, 2026 Twist Bioscience Corporation Grant or award +5,095 โ€” โ€”
Jun 11, 2025 908 Devices Inc. Option exercise +11,364 โ€” โ€”
Feb 5, 2025 Twist Bioscience Corporation Grant or award +4,472 โ€” โ€”
Jun 12, 2024 908 Devices Inc. Option exercise +7,777 โ€” โ€”
Feb 6, 2024 Twist Bioscience Corporation Grant or award +5,815 โ€” โ€”
Jun 14, 2023 908 Devices Inc. Option exercise +4,771 โ€” โ€”
Apr 3, 2023 Quanterix Corporation Grant or award +1,170 $11.16 $13,057
Feb 7, 2023 Twist Bioscience Corporation Grant or award +8,212 โ€” โ€”
Jan 3, 2023 Quanterix Corporation Grant or award +8,083 โ€” โ€”
Jan 3, 2023 Quanterix Corporation Grant or award +1,015 $12.86 $13,053

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.